Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Connective Capital Management LLC, the most common co-covered peer. We currently track 1 Biotech story that mention Shuttle Pharmaceuticals Holdings, Inc., all published on July 5, 2026.
Recent coverage · Shuttle Pharmaceuticals Holdings, Inc.
1story
avg impact
0%positive
0%negative
100% neutral
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Shuttle Pharmaceuticals Holdings, Inc.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention Connective Capital Management LLC, the most common co-covered peer. We currently track 1 Biotech story that mention Shuttle Pharmaceuticals Holdings, Inc., all published on July 5, 2026. Each carries 4 original sources on average.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Shuttle Pharmaceuticals Holdings, Inc.. Shared-story counts are live from our verified record — not editorial picks.
A $110,694 insider purchase by Financial Lp Hrt in Shuttle Pharmaceuticals boosts the owner’s stake to 78,597 shares just as the micro-cap trades near $2.90 lows. For biotech investors, this accumulation could reflect confidential knowledge about the radiation sensitizer pipeline's progress.
Shuttle Pharmaceuticals Holdings, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.